Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RSP vs GSK✓SelectedUSD · GSKRSP vs GSK performance historyLatest closeAs of-1.01%11/16
Stock and ETF performance explorer

RSP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.8%
GSK return
+46.9%
Excess return
-0.1%
Maximum drawdown
-21.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.0%-0.1%-0.9%-1.0%
7D-0.9%-1.3%+0.4%-0.7%
30D+2.3%+2.7%-0.5%+1.7%
3M-1.4%+2.7%-4.1%-2.0%
6M+9.4%+3.3%+6.1%+8.4%
YTD+15.7%+6.5%+9.2%+13.5%
1Y+18.7%+10.7%+8.1%+15.6%
3Y+58.7%+64.4%-5.6%+38.5%
5Y+46.8%+46.7%+0.1%+23.7%
All+46.8%+46.9%-0.1%+23.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling